Video Interview // ALZET® Osmotic Pumps
During the inaugural American Physiological Society Summit hosted in Long Beach, California, I spoke with Clarisa Peer, General Manager of ALZET, to discuss ALZET Osmotic Pumps, which are enabling novel and late-breaking research in a number of physiology related disciplines. These drug delivery devices have a proven track record, with over 21,000 published studies in various research areas, including cardiovascular, neuroscience, cancer research, pharmacology research, and more.
“Researchers really need reliable tools that consistently perform so they can focus on the scientific question. They need tools that don’t add confounds to the study that might cloud the research results.”
Quick Facts
- Consistent, continuous administration
- Cost effective
- Automated nighttime and weekend dosing
- Convenient for studies requiring chronic dosing
- Reduces animal handling and stress
- Minimizes experimental variables
- Targeted delivery
- Variety of sizes, release rates, durations
“The sky is the limit when it comes to the different areas that the pumps can be used in.”
It is no surprise that ALZET Osmotic Pumps have a reputation for success that speaks for itself. Considering how easy they are to use, and their applicability to a number of research areas; ALZET Osmotic Pumps are the gold standard for controlled, automatic dosing of compounds. Click to learn more about ALZET Osmotic Pumps.
Matthew Sparks, MD, explores the vascular-tubular crosstalk in the renin-angiotensin system that may play a key role in the regulation of pressure natriuresis.
Learn more about ALZET
The ALZET product line consists of miniature, implantable osmotic pumps and accessories used for experimental research in laboratory animals. ALZET Osmotic Pumps were developed during the 1970’s by ALZA Corporation. They were initially developed for use during internal company research, and for use by some of ALZA’s collaborators working at academic institutions. It did not take long for the word to spread about the existence of a novel drug delivery system that allowed for continuous administration of test agents into laboratory animals. The increasing demand for a commercially available continuous drug delivery device for animal research led to the introduction of ALZET pumps into the marketplace in 1977.
About the Author
Hayleigh Culliton is an accomplished scientific marketer with a background in Biology and Nursing. She obtained her Bachelor’s degree from Trent University, where she developed a strong passion for science communication. With 6 years of experience in scientific marketing, she has helped companies in the life sciences industry develop and execute effective marketing strategies and #ShareScience.